Koyfin Home > Directory > Health Care > Revance Therapeutics > Other Liabilities

Revance Therapeutics Other Liabilities Chart (RVNC)

Revance Therapeutics annual/quarterly Other Liabilities from 2012 to 2020.
  • Revance Therapeutics Other Liabilities for the quarter ending June 06, 2020 was $74m a 27.86% increase of 21m year over year
  • Revance Therapeutics Other Liabilities for the last 12 months ending June 06, 2020 was $74m a 27.86% increase of 21m year over year
  • Revance Therapeutics Annual Other Liabilities for 2019 was $48m a -1.69% decrease of -1m from 2018
  • Revance Therapeutics Annual Other Liabilities for 2018 was $49m a 87.79% increase of 43m from 2017
  • Revance Therapeutics Annual Other Liabilities for 2017 was $6m a 3.06% increase of 0m from 2016
Other Balance Sheet Metrics:
  • Revance Therapeutics Total Assets for the quarter ending September 09, 2018 was $233m a -26.88% decrease of -63m year over year
  • Revance Therapeutics Total Equity for the quarter ending September 09, 2018 was $182m a -47.64% decrease of -87m year over year
View Chart On Koyfin

Quarterly RVNC Other Liabilities Data

06/2020$74m
03/2020$47m
12/2019$48m
09/2019$54m
06/2019$35m
03/2019$41m
12/2018$49m
09/2018$19m
06/2018$21m
03/2018$25m

Annual RVNC Other Liabilities Data

2019$48m
2018$49m
2017$6m
2016$6m
2015$5m
2014$5m
2013$5m
2012$5m
2011$26m